C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 19/00 (2006.01) A61K 39/00 (2006.01) A61K 39/385 (2006.01) A61K 39/395 (2006.01) A61K 39/40 (2006.01) A61K 49/00 (2006.01) A61P 31/04 (2006.01) A61P 37/04 (2006.01) C07K 14/35 (2006.01) C07K 16/00 (2006.01) C12N 15/62 (2006.01)
Patent
CA 2640671
Provided are fusion polypeptides comprising an engineered antibody and a stress protein that bind to antigens with high affinity, are highly immunogenic, exhibit MHC class I priming and are able to be produced in non- mammalian cells, such as E. coli.
L'invention concerne des polypeptides de fusion comprenant un anticorps de synthèse et une protéine de stress. Ces polypeptides se lient aux antigènes avec une haute affinité, sont fortement immunogènes, présentent un amorçage de MHC de classe I et peuvent être produits dans des cellules non mammifères, et notamment dansE. coli.
Riches Mckenzie & Herbert Llp
The General Hospital Corporation
LandOfFree
Engineered antibody-stress protein fusions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Engineered antibody-stress protein fusions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered antibody-stress protein fusions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2077044